Skip to main content
. 2023 Sep 14;14(12):1383–1390. doi: 10.1111/jdi.14075

Figure 2.

Figure 2

(a) The total daily insulin dose in the first and second trimesters, and the peripartum period in the sensor‐augmented insulin pump therapy group, and (b) continuous subcutaneous insulin infusion plus self‐monitoring of the blood glucose group. Statistical significance was calculated using the Mann–Whitney U‐test with a Bonferroni correction.